Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches.

Naobios

#RECRUTEMENT - Nouvelle opportunité chez Naobios
🔎 Ingénieur Qualification (H/F), en CDI
➡️ Pour candidater, c'est ici: https://lnkd.in/enJ6NsAu 

#RECRUTEMENT - Nouvelle opportunité chez Naobios !
🔎 Business Developer, Permanent Position
➡️ Pour candidater, c'est ici : https://lnkd.in/eWgR3Qbn

Need support for GMP manufacturing of your vaccines, oncolytic viruses or challenge agents? 
With over 15 years' experience in process development and GMP manufacturing for clinical development, Naobios is your partner of choice for your virus-derived products !🔬🦠

◾ USP & DSP development capacities
◾ BSL2 & BSL3 GMP manufacturing
◾ Analytical development & validation
◾ GMP storage

You need more informations ? Contact us ! ➡️ https://lnkd.in/enFcEWQ4

#CDMO #vaccines #oncolyticviruses #challengeagents #manufacturing

Aujourd'hui Clean Cells et Naobios étaient présentes au forum des Métiers ouvert à l'ensemble des étudiants d'Oniris Nantes.

Les étudiants ont pu se projeter sur les métiers du domaine de la Biotechnologie, notamment grâce au partage d'expérience de Juliette Ambrosini et Céleste Ory, anciennes élèves d'Oniris désormais salariées du groupe CLEAN BIOLOGICS.

Merci à Oniris pour votre accueil, et merci aux étudiants qui sont venus à notre rencontre ! Au plaisir de futures collaborations !

#ForumdesMétiers #etudiants #talents #recrutement #RH Hélène Mercier

Extracellular vesicles (EVs) play an important role in the intercellular communication and are involved in physiological and pathological functions. They are attracting significant clinical interest for drug delivery, disease diagnosis and therapeutic intervention. EVs properties make their use promising for applications such as tissue regeneration and nano carriers able to cross biological barriers. To position EVs as new biotherapeutics, some of the current challenges are increasing production yields and improving quantification and characterization.

Thanks to its recognized experience in cell culture based process development, Naobios has the capabilities to implement bioreactors based platforms (stirred tank and fixed-bed) as well as EVs purification steps through filtration and chromatographic techniques.

Naobios is the right partner to make your EVs manufacturing processes compatible with industrial scale-up and GMP requirements.

#EVs #exosomes #purification #filtration #chromato #manufacturing #GMP 

| 📢 #BIOEurope2023 |

Last day to meet Luís Raiado from Naobios & François Pedelaborde from Clean Cells at the Bio-Europe Congress in Munich.

If you don't have the opportunity to meet them before tonight, please don't hesitate to contact us on our website. We'll be pleased to discuss about your upcoming projects ➡️ https://lnkd.in/enFcEWQ4

#congress #CRO #CDMO #bioprocessdevelopment #manufacturing CLEAN BIOLOGICS

VentureRadar provides innovation and growth scores, company information, and location for similar companies and competitors in the biotechnology industry.

VentureRadar

Biocompare shares updated information on viral vector production platforms, including transient transfection, and features leading companies in the gene therapy industry.

Biocompare

Clean Biologics has developed bioprocesses and manufactured BSL2/BSL3 viral vectors for clinical use in modalities such as viral vaccines, aligning with Naobios' expertise in viral vector-based products.

Clean Biologics

GlobalData uncovers leading innovators in gene therapy viral vectors for the pharmaceutical industry, providing valuable insights into companies driving advancements in viral vector-based products.

GlobalData

Naobios is a biotechnology company that specializes in the development and manufacturing of viral vector-based products for gene therapy and vaccination. The company offers a range of services including process development, GMP manufacturing, quality control, and regulatory support to advance therapies from early-stage research to clinical trials.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 12, 2024 3:58 PM	e7b1d843
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 12, 2024 9:44 PM	9cece234
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 12, 2024 3:58 PM	29ab3fe6
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 12, 2024 3:58 PM	b1204645
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:NAOBIOS

Naobios